Physician profile
Mark W Bachman
NPI 1326112384
$1,466.96
in general payments reported to CMS, 2019-2025
11 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.82 · 2022: $481 · 2023: $674 · 2024: $128 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880 · Education: $93.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.40 |
| Education | $93.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $867.48 | 2022-2024 | Invisalign System - Moderate, Invisalign |
| Dentsply Sirona INC | $280.26 | 2021-2025 | Ossix Plus, Primescan Connect, Cerec Tessera |
| Gc America INC. | $93.10 | 2025 | Cerasmart, Bio-Edge, Axcess |
| Straumann USA LLC | $83.11 | 2024-2025 | |
| Patterson Companies, INC. | $39.74 | 2022 | |
| Septodont INC. | $28.20 | 2024 | Biodentine |
| Solventum Corporation | $16.72 | 2024 | |
| Kerr Corporation | $15.77 | 2023 | Harmonize |
| Nobel Biocare USA | $15.77 | 2023 | Nobelactive |
| Ultradent Products INC | $13.82 | 2025 | Opalescence |
| 3m Company | $12.99 | 2023 | Clinpro 5000, Attest, Peridex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bachman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.